ArticleEuropean journal of medical research2025
Repeated cryopreservation is associated with poor pregnancy outcomes after frozen-thawed embryo transfer in women aged < 35 years: a propensity-score matched cohort study.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Once, twice, three times frozen: viability and post-transfer outcomes of fresh and vitrified-warmed mouse embryos.Human reproduction (Oxford, England) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundRepeated cryopreservation of embryos in frozen-thawed embryo transfer (FET) has raised concerns regarding its impact on pregnancy outcomes. This study aimed to reveal the association between repeated cryopreservation by vitrification and FET outcomes, and to identify factors influencing these outcomes.
methodsA single-center retrospective cohort study was conducted, analyzing 13,624 FET cycles (from 2018 to 2022) involving embryos with cryopreservation or repeated cryopreservation. Propensity score matching was employed in this study. The primary outcome was clinical pregnancy rate (CPR) while live birth rate (LBR), miscarriage along with neonatal outcomes were also assessed. Multivariate logistic regression and stratified analyses were used to explore the effect of female age and the quality of embryo on CPR after adjusting for confounders.
resultsIn total, 321 FET cycles met the inclusion and exclusion criteria were included after matching and divided into re-cryopreservation group (n = 107) and cryopreservation group (n = 214). The re-cryopreservation group showed lower CPR (27.10% vs. 45.33%; aOR, 0.48; 95% CI 0.28-0.84) and LBR (18.69% vs. 38.32%; aOR, 0.35; 95% CI 0.19-0.65), with no differences in miscarriage or biochemical pregnancy rates. Stratified analyses revealed an adverse effect of women aged < 35 years (aOR, 0.40; 95% CI 0.19-0.83) and single-embryo transfers (aOR, 0.51; 95% CI 0.28-0.94) on CPR while transfer of good quality embryos reduced these effects (aOR, 0.55; 95% CI 0.21-1.44). Gestational age, birthweight and congenital anomalies proportion were not significantly different between the two groups.
conclusionsRepeated cryopreservation was associated with reduced clinical pregnancy and live birth rates, particularly in younger patients. The neonatal outcomes were potentially not affected. Clinicians may consider limiting repeated cryopreservation for women under 35 years and prioritize good-quality embryos for re-vitrification when medically justified. These findings underscored the need for tailored strategies in FET cycles involving re-cryopreserved embryos.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.